Strike down to zero
migraine pain
with Ubrelvy®

Pain relief at 2 hours was demonstrated in 62% (UBRELVY 50 mg) vs 49% (placebo) when taken immediately or within 4 hours of onset3,4

Pain freedom at 2 hours (co-primary endpoint) was demonstrated in 21% (UBRELVY 50 mg) vs 13% (placebo).3 Sustained pain freedom from 2 to 24 hours (secondary endpoint) was achieved in 14% (UBRELVY 50 mg) vs 8% (placebo)1

UBRELVY has been prescribed over 2 million times by more than 80,000 HCPs, treating over 500,000 patients3

Ubrelvyhcp Hero Banner
ubrelvyhcp stamp.png

Strike down to zero
migraine pain
with Ubrelvy®

Ubrelvyhcp Rapid

RAPID: Quick pain relief1

Ubrelvyhcp Rapid

Pain relief at 2 hours was demonstrated in 62% (UBRELVY 50 mg) vs 49% (placebo) when taken immediately or within 4 hours of onset3,4

Ubrelvyhcp Powerfull

POWERFUL: Zero pain, sustained1,3

Ubrelvyhcp Powerfull

Pain freedom at 2 hours (co-primary endpoint) was demonstrated in 21% (UBRELVY 50 mg) vs 13% (placebo).3 Sustained pain freedom from 2 to 24 hours (secondary endpoint) was achieved in 14% (UBRELVY 50 mg) vs 8% (placebo)1

Ubrelvyhcp Proven Home banner

PROVEN: Well established in market3

Ubrelvyhcp Proven Home banner

UBRELVY has been prescribed over 2 million times by more than 80,000 HCPs, treating over 500,000 patients3

Streamline the prescribing process

Get patients started

Once you've decided to prescribe UBRELVY, enable access for your patients with our U-CONCIERGE program and learn how eligible patients may pay as little as $0—all pills, all fills.*

Help enable access
Prescribe the 16 count

16 count is available for your UBRELVY patients

Migraine attacks can be unpredictable.5 Prepare your patients with a 16-count package of UBRELVY 100 mg tablets.

View dosing
See the impact of UBRELVY

See the impact of UBRELVY

UBRELVY is part of a powerful migraine pain tool kit.1

See how it can help

*Patient out-of-pocket costs may vary. Terms and Conditions apply. This offer is only valid for commercially insured patients. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs.